Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,122Revenue $M103Net Margin (%)-86.5Altman Z-Score-6.1
Enterprise Value $M1,153EPS $-0.8Operating Margin %-69.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-86.3Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales10.35-y EBITDA Growth Rate %--Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-58.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M110ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MACKJoel Greenblatt 2015-03-31 Buy $8.78 - $12.48
($10.82)
$ 10.07-7%New holding13,433
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MACK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nielsen Ulrik B.Director 2015-07-20Sell20,000$10.71-5.98view
Sullivan William A.CFO and Treasurer 2015-07-15Sell15,000$11.85-15.02view
Stewart Edward J.Head of Commercial 2015-07-15Sell6,000$11.84-14.95view
Nielsen Ulrik B.Director 2015-06-19Sell40,000$12.02-16.22view
Stewart Edward J.Head of Commercial 2015-06-18Sell2,000$12-16.08view
Sullivan William A.CFO and Treasurer 2015-06-15Sell15,000$10.65-5.45view
Stewart Edward J.Head of Commercial 2015-06-15Sell6,000$10.67-5.62view
Nielsen Ulrik B.Director 2015-05-19Sell40,000$13.04-22.78view
Stewart Edward J.Head of Commercial 2015-05-15Sell8,000$12.33-18.33view
Sullivan William A.CFO and Treasurer 2015-05-15Sell15,000$12.37-18.59view

Quarterly/Annual Reports about MACK:

News about MACK:

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

More From Other Websites
MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jul 13 2015
Baxter's MAA for MM-398 Accepted in International Markets - Analyst Blog Jun 29 2015
MM-398 Receiving the Priority Review Designation by US FDA for New Drug Application and the... Jun 25 2015
3 Stocks Spiking on Unusual Volume Jun 25 2015
U.S. FDA Grants Priority Review for MM-398 New Drug Application Jun 25 2015
U.S. FDA Grants Priority Review for MM-398 New Drug Application Jun 25 2015
Should You Buy Merrimack Pharmaceuticals Inc (MACK) After The 10% Surge? Jun 19 2015
MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 16 2015
Merrimack Pharmaceuticals Announces the Addition of John M. Dineen, Former CEO of GE Healthcare, to... Jun 15 2015
Merrimack Pharmaceuticals Announces the Addition of John M. Dineen, Former CEO of GE Healthcare, to... Jun 15 2015
Merrimack Pharmaceuticals Announces Expansion of MM-398 (nal-IRI) Imaging Study to Patients with... Jun 11 2015
Merrimack Pharmaceuticals Announces Expansion of MM-398 (nal-IRI) Imaging Study to Patients with... Jun 11 2015
Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing... Jun 01 2015
Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing... Jun 01 2015
MERRIMACK PHARMACEUTICALS INC Financials May 15 2015
MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... May 14 2015
Merrimack Pharmaceuticals Announces Presentations at the 2015 American Society of Clinical Oncology... May 14 2015
Merrimack Pharmaceuticals Announces Presentations at the 2015 American Society of Clinical Oncology... May 14 2015
Lightning Round: Don't know why this is so cheap May 13 2015
Merrimack Pharmaceuticals' Q1 Loss Wider Than Expected - Analyst Blog May 08 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK